Dr. Jubin Puthenparampu Joseph, MD, PhD

Dr. Joseph practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Joseph's NPI, 1497341747, was assigned on December 20, 2020. Dr. Joseph graduated from Oxford University Medical School in 2008. Dr. Joseph holds California license A180893.

Dr. Joseph's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Joseph's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Joseph is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Joseph to 2 more hospitals, 1 group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Joseph practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Joseph's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Joseph is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization and pacemaker or defibrillator implantation among the conditions Dr. Joseph treats.

CMS data shows 1,424 Medicare services from Dr. Joseph across 16 procedure codes in 2024, for 768 Medicare patients. Medicare paid $112,655 for them.

CMS counts 768 Medicare patients who saw Dr. Joseph in 2024. The largest group is 65 to 74, with 333 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 3.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Joseph's median patient age at 67, with 42% women.

In 2024, Dr. Joseph wrote 435 Medicare Part D claims for 85 patients. 87% of them were for generic drugs. CMS names the drug for 388 of them, across 17 drugs with 11 or more claims each, at $41,716 in total drug cost. In 2023, CMS named 261 claims across 12 drugs.

Dr. Joseph accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Joseph as offering telehealth. CMS counts 81 procedures of coronary angioplasty and stenting by Dr. Joseph, more than 94% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Joseph, published from 2010 to 2022. 2017 was the busiest year, with 5. The most frequent topics are Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement and United Kingdom. Dr. Joseph has published most often in J Am Heart Assoc. Dr. Joseph's most frequent co-authors are Daniel Burkhoff, MD, PhD, Noman N. Ali, MD and Sam Dawkins, MD, PhD.

CMS Open Payments shows 680 general payments to Dr. Joseph from 16 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 46% of the total. Edwards Lifesciences Corporation paid the most, $95,517.

Dr. Joseph graduated from Oxford University Medical School in 2008.

Dr. Joseph is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.